Table 4.
SV40 seropositivity among Colombian ethnic groupsa
| Group | Group criteria | Ethnic group No. SV40 antibody positive/No. tested (%)b |
|||
|---|---|---|---|---|---|
| Mixed | White | Black | Unknown | ||
| A | Cervical cancer | 6/49 (12.2) | 5/16 (31.2) | 0/3 (0) | 1/2 (50.0) |
| B | Cancer controls | 5/36 (13.9) | 1/19 (5.3) | 1/13 (7.7) | 0/2 (0) |
| C | General populationc | 29/101 (27.7) | 28/111 (25.2) | 7/43 (16.3) | 10/51 (21.6) |
| D | Sex workersd | — | — | 13/41 (31.7) | 9/16 (56.2) |
| Total: | 40/186 (21.0) | 34/146 (23.3) | 20/100 (20.0) | 20/71 (29.6) | |
a
No ethnic categories were reported for Nicaraguan subjects.
b
Statistical significance: Mixed only, Group C-(vbc) vs. Groups A+B, p = 0.0867; White only, Group C-(vbc) vs. Groups A+B, p = 0.1384; Black only, Group C-(vbc) vs. Groups A+B, p = 0.3801; Black only, Group D vs. Group C, p = 0.097. (vbc) = Birth cohort that contains potential vaccinees (birth dates 1949–1960).
c
Samples that lacked ethnic group information were not included.
d
Only two ethnic categories were reported for Group D.